Repligen (RGEN) Construction in Progress (2011 - 2025)
Repligen's (RGEN) quarterly Construction in Progress came in at $28.4 million in Q4 2025, up 0.67% year-over-year from $28.2 million in Q4 2024, and up 12.93% quarter-over-quarter from $25.1 million in Q3 2025.
Analysis
Repligen (RGEN) Construction in Progress (2011 - 2025) Analysis & Trends
Repligen (RGEN) has reported Construction in Progress for 15 consecutive years, with $28.4 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Construction in Progress rose 0.67% year-over-year to $28.4 million in Q4 2025; TTM through Dec 2025 was $28.4 million, a 0.67% increase from a year earlier, with the FY2025 full-year figure at $28.4 million, up 0.67% from the prior year.
- Construction in Progress was $28.4 million for Q4 2025 at Repligen, up from $25.1 million in the prior quarter.
- Over five years, Construction in Progress peaked at $77.8 million in Q2 2022 and troughed at $7.9 million in Q2 2021.
- A 5-year average of $36.3 million and a median of $31.3 million in 2022 frame the typical range for Construction in Progress.
- Across the five-year window, Construction in Progress soared 879.69% in 2022 and plunged 60.05% in 2023, its largest moves.
- Over 5 years, Construction in Progress stood at $38.4 million in 2021, then dropped by 17.93% to $31.6 million in 2022, then surged by 49.23% to $47.1 million in 2023, then slumped by 40.09% to $28.2 million in 2024, then advanced by 0.67% to $28.4 million in 2025.
- The last three Construction in Progress figures came in at $28.4 million (Q4 2025), $25.1 million (Q3 2025), and $25.9 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | - |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | - |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | - |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | - |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 28.40 Mn |
| Sep 30, 2025 | 25.15 Mn |
| Jun 30, 2025 | 25.94 Mn |
| Mar 31, 2025 | 25.49 Mn |
| Dec 31, 2024 | 28.21 Mn |
| Sep 30, 2024 | 40.24 Mn |
| Jun 30, 2024 | 54.33 Mn |
| Mar 31, 2024 | 53.07 Mn |
| Dec 31, 2023 | 47.09 Mn |
| Sep 30, 2023 | 37.68 Mn |
| Jun 30, 2023 | 31.08 Mn |
| Mar 31, 2023 | 30.89 Mn |
| Dec 31, 2022 | 31.55 Mn |
| Sep 30, 2022 | 53.45 Mn |
| Jun 30, 2022 | 77.81 Mn |
| Mar 31, 2022 | 54.34 Mn |
| Dec 31, 2021 | 38.45 Mn |
| Sep 30, 2021 | 14.72 Mn |
| Jun 30, 2021 | 7.94 Mn |
| Mar 31, 2021 | 19.35 Mn |